Your browser doesn't support javascript.
loading
Cyclosporin A but not FK506 activates the integrated stress response in human cells.
Fedele, Anthony O; Carraro, Valérie; Xie, Jianling; Averous, Julien; Proud, Christopher G.
Affiliation
  • Fedele AO; Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health & Medical Research Institute, North Terrace Campus, Adelaide, Australia.
  • Carraro V; INRAE Unité de Nutrition Humaine, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Xie J; Lifelong Health Theme, South Australian Health & Medical Research Institute, North Terrace Campus, Adelaide, Australia.
  • Averous J; INRAE Unité de Nutrition Humaine, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Proud CG; Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health & Medical Research Institute, North Terrace Campus, Adelaide, Australia; Lifelong Health Theme, South Australian Health & Medical Research Institute, North Terrace Campus, Adelaide, Australia; School of Biologica
J Biol Chem ; 295(44): 15134-15143, 2020 10 30.
Article in En | MEDLINE | ID: mdl-32843478
ABSTRACT
Cyclosporin A (CsA) and tacrolimus (FK506) are valuable immunosuppressants for a range of clinical settings, including (but not limited to) organ transplantation and the treatment of autoimmune diseases. They function by inhibiting the activity of the Ca2+/calmodulin-dependent phosphatase calcineurin toward nuclear factor of activated T-cells (NF-AT) in T-lymphocytes. However, use of CsA is associated with more serious side effects and worse clinical outcomes than FK506. Here we show that CsA, but not FK506, causes activation of the integrated stress response (ISR), an event which is normally an acute reaction to various types of intracellular insults, such as nutrient deficiency or endoplasmic reticulum stress. These effects of CsA involve at least two of the stress-activated protein kinases (GCN2 and PERK) that act on the translational machinery to slow down protein synthesis via phosphorylation of the eukaryotic initiation factor (eIF) 2α and thereby induce the ISR. These actions of CsA likely contribute to the adverse effects associated with its clinical application.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Stress, Physiological / Tacrolimus / Cyclosporine / Immunosuppressive Agents Limits: Animals / Humans Language: En Journal: J Biol Chem Year: 2020 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Stress, Physiological / Tacrolimus / Cyclosporine / Immunosuppressive Agents Limits: Animals / Humans Language: En Journal: J Biol Chem Year: 2020 Type: Article Affiliation country: Australia